Antibodies Binding to Vista at Acidic pH
US-2025129166-A1 · Apr 24, 2025 · US
This page is not indexed by search engines while we improve data quality.
Five Prime Therapeutics Inc — Cross-Sectional Technologies
Five Prime Therapeutics Inc holds 5 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Five Prime Therapeutics Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 5 |
| Recent patents in slice | 2 |
| First year | 2019 |
| Last year | 2025 |
Representative patents
Notable publications linking Five Prime Therapeutics Inc to Cross-Sectional Technologies.
Antibodies binding to vista at acidic pH
US-12173069-B2 · Dec 24, 2024 · US
Antibodies Binding to Vista at Acidic pH
US-2021017283-A1 · Jan 21, 2021 · US
NOPE for treatment of pathological muscle loss and weakness
US-10799559-B2 · Oct 13, 2020 · US
Nope for treatment of pathological muscle loss and weakness
US-2019125833-A1 · May 2, 2019 · US
Recent filings
Latest patents from Five Prime Therapeutics Inc in Cross-Sectional Technologies.
Antibodies Binding to Vista at Acidic pH
US-2025129166-A1 · Apr 24, 2025 · US
Antibodies binding to vista at acidic pH
US-12173069-B2 · Dec 24, 2024 · US
Antibodies Binding to Vista at Acidic pH
US-2021017283-A1 · Jan 21, 2021 · US
NOPE for treatment of pathological muscle loss and weakness
US-10799559-B2 · Oct 13, 2020 · US
Nope for treatment of pathological muscle loss and weakness
US-2019125833-A1 · May 2, 2019 · US
Related pages
Navigate to parent entity pages.